Image

A Study of the Possible Effects of Medication on Young Onset Colorectal Cancer (YOCRC)

A Study of the Possible Effects of Medication on Young Onset Colorectal Cancer (YOCRC)

Recruiting
18-49 years
All
Phase N/A

Powered by AI

Overview

This study will collect biospecimens (including blood, tissue, and stool samples) and health information to create a database-a type of collection of information-for better understanding young onset colorectal cancer (YOCRC). The study will include both people with YOCRC and healthy people.

Eligibility

Inclusion Criteria:

CRC Cohort:

  • 18-49 years old
  • Histological or cytological diagnosis of colorectal adenocarcinoma
  • Planned CRC resection biopsy, or colonoscopy ,including surveillance colonoscopies and/or have already undergone prior surgical resection, with tissue, including normal colonic mucosae distant from the malignant tumor (only patients providing tissue sample)
  • Enrollment in IRB# 20-315, Young Onset Gastrointestinal Cancer Prospective Registry (Andrea Cercek, PI)

Healthy Control Cohort:

  • 18-49 years old
  • Scheduled for standard-of-care colonoscopy at MSK

Exclusion Criteria:

  • CRC Cohort:
  • Antibiotic use within 6 months of collection of stool for gut microbiome analysis s (only patients providing stool sample)
  • Known inherited cancer susceptibility gene
  • History of inflammatory bowel disease

Healthy Control Cohort:

  • Antibiotic use within 6 months of collection of stool for gut microbiome analysis (only patients providing stool sample)
  • History of or prior treatment for cancer ≤ 5 years prior to registration. Exceptions include non-melanoma skin cancer, ductal carcinoma in situ, bladder carcinoma in situ, or carcinoma-in-situ of the cervix.
  • Colonoscopy for indications of IBD, anemia and/or genetic predisposition (only patients providing tissue sample).

Study details
    Colorectal Cancer

NCT05568420

Memorial Sloan Kettering Cancer Center

26 January 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.